Aurora Cannabis Inc
NASDAQ: ACB
$7.38
-$0.23 (-3.0%)
Closing price May 17, 2024
ACB Articles
Aphria stays strong while Green Growth, which tried to buy it, goes bust. Canadian rival Aurora buys U.S. hemp retailer Reliva.
Published:
Investors can’t figure out if it’s dawn or dusk for Aurora Cannabis, and that means a wild ride for the stock.
Published:
High times in hard times? Tilray says pot should be seen as a consumer staple rather than an indulgence.
Published:
Canadian pot company Aphria is well positioned in the medical and recreational sectors. It has eyes on Europe but the coronavirus has stalled legalization efforts in the U.S.
Published:
Canadian pot grower Aurora Cannabis posted a solid beat over analysts' revenue expectations and shares are booming as a result.
Published:
Cannabis stocks have disappointed but the coronavirus lockdown might boost consumer demand.
Published:
Chesapeake stock runs out of energy as coronavirus cuts demand for oil faster than producers cut supply.
Published:
That last year was a terrible one for marijuana stocks is indisputable. So far, 2020 has not been much kinder, with Tilray shares down by more than 50% year to date. Yet, the company said it expects...
Published:
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Published:
A 12-for-1 reverse stock split by Canada-based pot grower Aurora Cannabis became effective Monday. The change was necessary to maintain the company's listing on the New York Stock Exchange.
Published:
Is Aurora Cannabis headed for bankruptcy reorganization? The signs are unmistakable, though maybe not unavoidable.
Published:
Here's a look at what has caused Canada's marijuana sales to increase so slowly, what impact that had on Aphria in particular, and how the pandemic will affect that company's future.
Published:
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Published:
In pandemic times, solid balance sheets have been a beacon of hope to investors, and for those wishing to get into the cannabis industry, a cash-rich company like Aphria may be that vehicle.
Published:
The March 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Published: